NEW YORK, NY--(Marketwired - April 27, 2017) - Artemis Therapeutics, Inc. (OTC PINK: ATMS), ("Artemis" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of ...

Credit: Getty Images This review provides a concise overview of the epidemiology, etiology, history, diagnostic criteria, and management of CMV infection in solid organ transplant recipients.

Among the recipients of allogeneic bone marrow or peripheral blood stem cells at five transplant centers, those who developed histologically diagnosed CMV-GI disease were enrolled into this study.

Cytomegalovirus (CMV) is a common virus. According to the Centers for Disease Control and Prevention (CDC), it infects between 50 to 80 percent of all adults by the time they reach 40 years old.

Routine diagnostic strategies for CMV disease have included viral culture and shell vial assays. However, these are inefficient and have poor sensitivity. The CMV antigenaemia assay is currently ...

Wendy van Zuijlen does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond ...